Skip to content

More Time Better Outcome - a Randomised Trial to Investigate the Effect of More Dietetic Time in Dialysis Patients

More Time Better Outcome - a Randomised Trial to Investigate the Effect of More Dietetic Time on Phosphate Levels in End Stage Renal Failure Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00755768
Enrollment
75
Registered
2008-09-19
Start date
2006-01-31
Completion date
2006-09-30
Last updated
2008-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure

Keywords

hemodialysis, phosphate, calcium phosphate product, dietician, dietetic advice

Brief summary

The purpose of this study is to determine whether spending more time with a dietitian will improve dietary compliance in a group of hemodialysis patients, with particular respect to phosphate control.

Detailed description

* randomised prospective controlled trial * stable haemodialysis patients on thrice weekly haemodialysis (URR \> 66%) * either had standard dietetic review - 6 monthly or intensive review - monthly * all patients had to have a serum phosphate \> 1.8 mmol/l over the previous three months to be recruited * study period 6 months, and then patients followed for a further 3 months

Interventions

BEHAVIORALadditional review by dietician

Sponsors

Royal Free Hampstead NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* stable chronic hemodialysis patients * serum phosphate \> 1.8 mmol/l sustained over 3 months prior to trial entry adequate dialysis treatment as assessed by urea reduction

Exclusion criteria

* pregnancy * unable to give consent * phosphate \< 1.8 mmol/l * inadequate dialysis * aged \< 18 or \> 80 * poor nutritional state * weight loss in proceeding three months

Design outcomes

Primary

MeasureTime frame
phosphate control
calcium phosphate product

Secondary

MeasureTime frame
parathyroid hormone
number and type of phosphate binders prescribed

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026